Moderna Vaccine Is Better Than Pfizer-BioNTech at Tackling Delta Variant, US Study Found The Pfizer-BioNTech vaccine's efficacy has dropped to 42 percent from 76 percent since the Delta variant took hold. By Sissi Cao
A.I. Models Can Exhibit Human-Like Gambling Addiction Behaviors: Study By Alexandra Tremayne-Pengelly
This $2.6B Japanese A.I. Startup Exposes the Language Gap in Today’s LLMs By Alexandra Tremayne-Pengelly
